ReviewInternational journal of nanomedicine2025
Emerging Role of Plant-Derived Nanostructures in Nanomedicine.
Review in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Engineering pectin- and sodium alginate-based nanoemulgels for topical delivery ofRSC advances · 2026Article
- Development trends and translational opportunities in self-assembled herbal bioactive materials research.Discover nano · 2026Review
- Plant-derived nanocarriers & nanostructures for barrier-defined translation: a comprehensive review of mechanisms, targets, and translation.Journal of nanobiotechnology · 2026Review
- Emerging Nanoplatforms are Effective Against Tumor Hypoxia.International journal of nanomedicine · 2026Review
- Advancing Arthritis Therapy: The Frontier of Targeted and Responsive Nanomedicine.International journal of nanomedicine · 2026Review
- Editorial: Pharmacological advancements of novel natural-based nanomedicines.Frontiers in pharmacology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Plant-derived nanostructures (PDNSs) represent a promising class of natural nanomedicines that integrate therapeutic and drug delivery functions. These self-assembled nanosystems, including nanoparticles, nanovesicles, exosomes, and nanofibers, leverage bioactive phytoconstituents to overcome limitations of synthetic biomaterials, such as immunogenicity and suboptimal targeting. PDNSs exhibit unique advantages like high biocompatibility, autonomous formation, and multi-modal functionality. This review examines their structural classification, fabrication methods and characterization techniques. PDNSs, synergistically combining inherent biological activities with engineered delivery properties, are revolutionizing conventional drug delivery systems and therapeutic approaches. Their applications expand into a remarkable spectrum of medical fields, demonstrating outstanding efficacy in oncology, inflammatory disorders, infectious diseases, and tissue engineering. Furthermore, PDNSs exhibit transformative potential in addressing complex neurological and metabolic conditions. Their eco-friendly production, low toxicity, and ability to penetrate biological barriers (eg, the absorption barrier and the blood-brain barrier) establish them as the next frontier in therapeutic development. This review critically evaluates the immense potential of PDNSs to bridge natural medicine and precision nanomedicine, offering translational insights for future applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.